G-BA Assessment Outcomes

Rephrase with Ginger (Cmd+⌥+E)

FDA Approves GSK’s Nucala for COPD Patients with Eosinophilic Inflammation

The U.S. Food and Drug Administration (FDA) has approved GSK’s biologic therapy, Nucala (mepolizumab), as an add-on maintenance treatment...

TOP PHARMACEUTICAL COMPANIES 2025 Rank Company Q1 H1 9M Annual 1 Johnson & Johnson $21.9 2 Roche $18.7 3 Pfizer $13.7 4 Merck $13.6 5...

AZD0780, a New Oral PCSK9 Inhibitor, Shows Strong LDL-C Lowering Effects in Phase IIb PURSUIT Study AZD0780, a once-daily oral PCSK9...